Why It Matters
Two proposed federal regulations would significantly restrict access to gender-affirming medical care for minors across Connecticut and the broader United States. The rules would affect hospitals and state Medicaid programs that receive federal funding, cutting off services already in flux following recent decisions by major Connecticut health systems.
What Happened
The federal government has advanced two separate proposed rules targeting gender-affirming clinical care for patients under 18 and 19. The first, known as the Hospital Conditions of Participation Rule, would prohibit Medicare and Medicaid-participating hospitals from providing gender-affirming clinical care to patients younger than 18. Hospitals that fail to comply could lose access to federal Medicare and Medicaid reimbursements — a potentially existential financial consequence for most major health systems.
The second measure, the Medicaid and CHIP Funding Prohibition Rule, would bar the use of federal Medicaid and CHIP dollars for gender-affirming care for anyone under 19. Because Medicaid is jointly funded by the federal government and individual states, the rule would reshape how Connecticut and other states can spend health coverage dollars on this patient population.
In February, advocacy organizations including Out Accountability Project and Equality Connecticut gathered and submitted public comments on the proposed rules. The Global Health Justice Partnership also submitted formal comments. More than 100 firsthand accounts were included in the submissions, with participants describing what they characterized as the medical necessity of such treatments and the risks posed by reduced access.
Connecticut Already Seeing Disruption
The federal proposals arrive against a backdrop of significant local change. Yale New Haven Health and Connecticut Children’s Medical Center both discontinued gender-affirming medical treatment last summer, decisions that affected roughly 1,100 young patients who had been receiving clinical care through those institutions. That loss of access preceded the federal rulemaking, underscoring how quickly the landscape has shifted for this population in Connecticut.
The state’s healthcare infrastructure has seen significant financial and organizational activity in recent months, with institutions navigating both funding pressures and shifting federal policy environments simultaneously.
By the Numbers
- 1,100: Approximate number of Connecticut youth who lost access to clinical gender-affirming care after Yale New Haven Health and Connecticut Children’s Medical Center ended those services last summer.
- 100+: Firsthand accounts submitted in public comments describing personal experiences with gender-affirming care access.
- 2 separate proposed federal rules targeting different funding streams — Medicare/Medicaid hospital participation and direct Medicaid/CHIP reimbursement.
- Under 19: The age threshold set by the Medicaid and CHIP Funding Prohibition Rule — one year broader than the hospital participation rule’s under-18 threshold.
Zoom Out
The proposed federal rules align with actions taken by more than two dozen states that have enacted legislative or regulatory restrictions on gender-affirming care for minors since 2021. The federal approach, however, would extend the policy reach into states like Connecticut that have maintained legal protections for such care at the state level. By tying restrictions to Medicare and Medicaid participation, the rules create a financial enforcement mechanism that operates independently of state law.
The World Health Organization defines gender-affirming care broadly to include social, psychological, behavioral, and medical interventions intended to support an individual’s gender identity. The proposed federal rules would apply specifically to the clinical and medical components of that spectrum for minors.
The debate over who holds decision-making authority in pediatric medical care — parents, physicians, state governments, or federal regulators — has become a central fault line in health policy nationally. Supporters of the proposed rules argue that federal funding should not be used for treatments they consider experimental or harmful to minors, while opponents contend that restricting care options undermines physician judgment and parental autonomy. Connecticut has also been investing in youth-focused programs in other sectors, reflecting ongoing state-level attention to the needs of young residents.
What’s Next
The public comment period has closed, and federal agencies will review submitted comments before issuing final rules. Connecticut health advocates and legal organizations are expected to monitor the rulemaking closely, and legal challenges are considered likely if the rules are finalized as proposed. State officials have not yet publicly outlined how Connecticut would respond to a final rule conflicting with existing state protections.